Title
Age-related prevalence of Shigella and Salmonella antibodies and their association with diarrhoeal diseases in Peruvian children
Date Issued
01 January 1998
Access level
metadata only access
Resource Type
journal article
Publisher(s)
Informa Healthcare
Abstract
Shigella and Salmonella antibodies in relation to diarrhoea were studied in a cohort of 413 children between 2 and 27 months of age in peri-urban Lima, Peru. Blood samples were obtained at 2, 3 and 12 months of age. Antibody titres against lipopolysaccharide from Shigella flexneri serotype Y, Shigella dysenteriae serotype 1, Shigella sonnei, Salmonella serogroups AO, BO, DO, and Shigella Ipa and Salmonella typhi Vi antigens were measured by enzyme immunoassay. IgG titres against S. flexneri and Shigella Ipa were higher at 2 than at 3 or 12 months of age (p = 0.001), while the changes in IgG titres against S. dysenteriae, S. sonnei and Salmonella were not pronounced. IgA and IgM titres against S. flexneri, Shigella Ipa, S. dysenteriae, S. sonnei and Salmonella were significantly higher at 12 than at 2 or 3 months of age (p = 0.001). Stool samples were obtained from children in 64% of all diarrhoeal episodes, Shigella spp. were isolated from 20% of the children during the first 2 y of lift and Salmonella in 3%. Most isolates were from children at 13-24 months of age (78%). IgG antibodies at 12 months of age did not protect against shigellosis during the second year of life.
Start page
159
End page
164
Volume
30
Issue
2
Language
English
OCDE Knowledge area
Pediatría Medicina general, Medicina interna
Scopus EID
2-s2.0-0031842548
PubMed ID
Source
Scandinavian Journal of Infectious Diseases
ISSN of the container
0036-5548
Sponsor(s)
Written informed consent was obtained from the parents of participating children. The study was approved by the Peruvian Ministry of Health, the Peruvian College of Physicians, the ethics committees of the Instituto de Investigación Nutricional Peru, the Clinical Research Subpanel of the National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH) USA, the Johns Hopkins School of Hygiene and Public Health USA, and the Pan-American and World Health Organizations and by community leaders of the study area.
Sources of information: Directorio de Producción Científica Scopus